Keros Therapeutics (KROS) Tax Provisions (2020 - 2025)
Keros Therapeutics (KROS) posted Tax Provisions of -$1.5 million for Q4 2025, down 6.32% on a QoQ basis from -$1.4 million in Q3 2025, and down 604.67% year-over-year from $300000.0 in Q4 2024.
Keros Therapeutics (KROS) Tax Provisions (2020 - 2025) Analysis & Trends
Keros Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at -$1.5 million for Q4 2025.
- Quarterly Tax Provisions fell 604.67% year-over-year to -$1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (up 1527.67% YoY) and the FY2025 annual result came in at $4.9 million, up 1527.67% from the prior year.
- Tax Provisions was -$1.5 million for Q4 2025 at Keros Therapeutics, down from -$1.4 million in the prior quarter.
- Across five years, Tax Provisions topped out at $10.0 million in Q1 2025 and bottomed at -$2.2 million in Q2 2025.
- A 3-year average of $899250.0 and a median of $6000.0 in 2021 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions surged 129.07% — and 2025, when it slumped 604.67%.
- Keros Therapeutics' Tax Provisions stood at $2.0 million in 2021, then plunged by 84.99% to $300000.0 in 2024, then slumped by 604.67% to -$1.5 million in 2025.
- Business Quant data shows KROS's Tax Provisions at -$1.5 million in Q4 2025, -$1.4 million in Q3 2025, and -$2.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - | -1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.51 Mn |
| Sep 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 10.04 Mn |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | -38,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Mar 31, 2020 | -172,000.00 |